GlassScriptPhysician profile
Shivani Sharma
NPI 1376704627
$1,480.91
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.10 · 2020: $57.37 · 2021: $128 · 2022: $519 · 2023: $688 · 2024: $62.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $750.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $139.82 | 2022-2023 | Ubrelvy, Qulipta |
| Novo Nordisk INC | $139.14 | 2020-2023 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $138.32 | 2021-2024 | Farxiga, Airsupra, Breztri |
| Lilly USA, LLC | $113.77 | 2022-2023 | Jardiance, Mounjaro, Trulicity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $106.27 | 2022-2023 | Jardiance |
| Glaxosmithkline, LLC. | $99.68 | 2019-2022 | |
| Amgen INC. | $92.79 | 2023 | Repatha, Otezla |
| Supernus Pharmaceuticals, INC. | $87.50 | 2022-2023 | Qelbree |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $77.02 | 2022-2024 | Caplyta |
| Pfizer INC. | $73.56 | 2021-2023 | |
| Abbott Laboratories | $72.53 | 2022-2024 | Freestyle Libre 3 |
| Bausch Health US, LLC | $54.65 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $52.35 | 2022 | |
| Neos Therapeutics, LP | $40.93 | 2022 | |
| Corium, LLC | $31.01 | 2023 | Azstarys |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $30.85 | 2023-2024 | Quviviq |
| Astellas Pharma US INC | $24.95 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $19.99 | 2021 | |
| Janssen Pharmaceuticals, INC | $16.69 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.06 | 2022 | |
| Exact Sciences Corporation | $14.06 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $13.64 | 2020 | |
| Ironshore Pharmaceuticals INC. | $13.60 | 2023 | Jornay Pm |
| Amarin Pharma, INC. | $12.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shivani Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.